Advisory Committee Meeting

June 28, 2023 at 9:30am - 5:30pm Eastern Time (US & Canada)

The Metabolic Drugs Advisory Committee will meet on Wednesday, June 28, to review Ipsen's new drug application (NDA) 215559 for palovarotene capsules.

The Open Public Hearing will be broadcast from 2 to 3 pm ET. Members of the FOP community will share testimony during this one-hour period.

Access the YouTube link and meeting materials


Make a Difference

Donate Connect Fundraise
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter